Lund, Line
Brautsch, Louise Ayoe Sparvath
Hoeeg, Didde
Pedersen, Natascha Holbæk
Thomsen, Louise Thirstrup
Larsen, Malte Nejst
Krustrup, Peter
Damsgaard, Camilla Trab
Toft, Ulla
Krølner, Rikke Fredenslund
Funding for this research was provided by:
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Novo Nordisk Fonden (NNF22SA0077224)
Article History
Received: 7 June 2024
Accepted: 4 November 2024
First Online: 19 November 2024
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and was approved by The Regional Committee on Health Research Ethics for Southern Denmark (reference number S-20220059). Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin.
: Not applicable.
: The authors declare no competing interests.